X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Novartis with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs MYLAN (US) - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   MYLAN
EQUITY SHARE DATA
    NOVARTIS
Mar-16
MYLAN
Dec-14
NOVARTIS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs9823,806-   
Low Rs5562,682-   
Sales per share (Unadj.) Rs252.91,303.0-  
Earnings per share (Unadj.) Rs62.1157.0-  
Cash flow per share (Unadj.) Rs63.3252.7-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs363.6647.7-  
Shares outstanding (eoy) m31.96378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x3.02.5 122.1%   
Avg P/E ratio x12.420.7 59.9%  
P/CF ratio (eoy) x12.212.8 94.6%  
Price / Book Value ratio x2.15.0 42.2%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m24,5801,227,466 2.0%   
No. of employees `0000.825.0 3.0%   
Total wages/salary Rs m1,8010-   
Avg. sales/employee Rs Th10,748.919,720.0 54.5%   
Avg. wages/employee Rs Th2,395.20-   
Avg. net profit/employee Rs Th2,641.12,375.6 111.2%   
INCOME DATA
Net Sales Rs m8,083492,999 1.6%  
Other income Rs m829-2,874 -28.9%   
Total revenues Rs m8,913490,126 1.8%   
Gross profit Rs m234122,611 0.2%  
Depreciation Rs m3736,209 0.1%   
Interest Rs m221,265 0.0%   
Profit before tax Rs m1,02562,264 1.6%   
Minority Interest Rs m0-255 0.0%   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m7522,618 28.7%   
Profit after tax Rs m1,98659,390 3.3%  
Gross profit margin %2.924.9 11.6%  
Effective tax rate %73.44.2 1,744.5%   
Net profit margin %24.612.0 204.0%  
BALANCE SHEET DATA
Current assets Rs m12,678433,411 2.9%   
Current liabilities Rs m2,433338,841 0.7%   
Net working cap to sales %126.719.2 660.7%  
Current ratio x5.21.3 407.4%  
Inventory Days Days3378 41.9%  
Debtors Days Days22107 21.0%  
Net fixed assets Rs m69114,054 0.1%   
Share capital Rs m16017,434 0.9%   
"Free" reserves Rs m11,4600-   
Net worth Rs m11,621245,069 4.7%   
Long term debt Rs m0366,109 0.0%   
Total assets Rs m14,400987,116 1.5%  
Interest coverage x570.53.9 14,524.2%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x0.60.5 112.4%   
Return on assets %13.88.2 169.0%  
Return on equity %17.124.2 70.5%  
Return on capital %23.613.6 173.0%  
Exports to sales %0.70-   
Imports to sales %18.60-   
Net fx Rs m-1,6350-   
CASH FLOW
From Operations Rs m2,53164,805 3.9%  
From Investments Rs m-8,270-51,107 16.2%  
From Financial Activity Rs m-386-17,076 2.3%  
Net Cashflow Rs m-6,125-3,378 181.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 63.86 Rs / USD

Compare NOVARTIS With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: UNICHEM LAB  PLETHICO PHARMA  ABBOTT INDIA  SUN PHARMA  AJANTA PHARMA  



Today's Market

Of Sensex Touching Record Highs, Rally in Banking Stocks and Key Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,000 on Wednesday and further inched upwards to end yesterday's trade at a level of 35,260.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jan 19, 2018 09:33 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS